دورية أكاديمية

Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway

التفاصيل البيبلوغرافية
العنوان: Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway
المؤلفون: Yang, Xiaoxia, Shang, Pengfei, Yu, Bingfang, Jin, Qiuyang, Liao, Jing, Wang, Lei, Ji, Jianbo, Guo, Xiuli
المصدر: In Acta Pharmaceutica Sinica B September 2021 11(9):2819-2834
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22113835
DOI:10.1016/j.apsb.2021.06.003